FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092362987> ?p ?o ?g. }

• W3092362987 endingPage "363" @default.
• W3092362987 startingPage "353" @default.
• W3092362987 abstract "Teicoplanin is a highly protein-bound antibiotic, increasingly used to treat serious Gram-positive infections in critically ill children. Maturational and pathophysiological intensive care unit-related changes often lead to altered pharmacokinetics. In this study, the objectives were to develop a pediatric population-pharmacokinetic model of unbound and total teicoplanin concentrations, to investigate the impact of plasma albumin levels and renal function on teicoplanin pharmacokinetics, and to evaluate the efficacy of the current weight-based dosing regimen. An observational pharmacokinetic study was performed and blood samples were collected for quantification of unbound and total concentrations of teicoplanin after the first dose and in assumed steady-state conditions. A population-pharmacokinetic analysis was conducted using a standard sequential approach and Monte Carlo simulations were performed for a probability of target attainment analysis using previously published pharmacokinetic–pharmacodynamic targets. A two-compartment model with allometric scaling of pharmacokinetic parameters and non-linear plasma protein binding best described the data. Neither the inclusion of albumin nor the renal function significantly improved the model and no other covariates were supported for inclusion in the final model. The probability of target attainment analysis showed that the standard dosing regimen does not satisfactory attain the majority of the proposed targets. We successfully characterized the pharmacokinetics of unbound and total teicoplanin in critically ill pediatric patients. The highly variable unbound fraction of teicoplanin could not be predicted using albumin levels, which may support the use of therapeutic drug monitoring of unbound concentrations. Poor target attainment was shown for the most commonly used dosing regimen, regardless of the pharmacokinetic–pharmacodynamic target evaluated." @default.
• W3092362987 created "2020-10-15" @default.
• W3092362987 creator A5012260179 @default.
• W3092362987 creator A5029554897 @default.
• W3092362987 creator A5032275750 @default.
• W3092362987 creator A5040815433 @default.
• W3092362987 creator A5044112673 @default.
• W3092362987 creator A5050357488 @default.
• W3092362987 creator A5059283543 @default.
• W3092362987 creator A5061152501 @default.
• W3092362987 creator A5075422062 @default.
• W3092362987 creator A5090770279 @default.
• W3092362987 date "2020-10-08" @default.
• W3092362987 modified "2023-10-07" @default.
• W3092362987 title "Population Pharmacokinetics of Unbound and Total Teicoplanin in Critically Ill Pediatric Patients" @default.
• W3092362987 cites W1776260563 @default.
• W3092362987 cites W1964215487 @default.
• W3092362987 cites W1980339260 @default.
• W3092362987 cites W1982428643 @default.
• W3092362987 cites W1982910325 @default.
• W3092362987 cites W1985541366 @default.
• W3092362987 cites W1989366534 @default.
• W3092362987 cites W2000882966 @default.
• W3092362987 cites W2001650311 @default.
• W3092362987 cites W2010530433 @default.
• W3092362987 cites W2012034837 @default.
• W3092362987 cites W2032754624 @default.
• W3092362987 cites W2046016030 @default.
• W3092362987 cites W2053647956 @default.
• W3092362987 cites W2062244594 @default.
• W3092362987 cites W2072529060 @default.
• W3092362987 cites W2075414761 @default.
• W3092362987 cites W2079421411 @default.
• W3092362987 cites W2079655167 @default.
• W3092362987 cites W2085521342 @default.
• W3092362987 cites W2088996598 @default.
• W3092362987 cites W2115089466 @default.
• W3092362987 cites W2154562175 @default.
• W3092362987 cites W2166879198 @default.
• W3092362987 cites W2179110505 @default.
• W3092362987 cites W2540968481 @default.
• W3092362987 cites W2550207834 @default.
• W3092362987 cites W2576366868 @default.
• W3092362987 cites W2604668335 @default.
• W3092362987 cites W2756286376 @default.
• W3092362987 cites W2763407146 @default.
• W3092362987 cites W2777918535 @default.
• W3092362987 cites W2789995793 @default.
• W3092362987 cites W2791247366 @default.
• W3092362987 cites W2899059770 @default.
• W3092362987 cites W2998780671 @default.
• W3092362987 cites W4210796249 @default.
• W3092362987 cites W4376542907 @default.
• W3092362987 doi "https://doi.org/10.1007/s40262-020-00945-4" @default.
• W3092362987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33030704" @default.
• W3092362987 hasPublicationYear "2020" @default.
• W3092362987 type Work @default.
• W3092362987 sameAs 3092362987 @default.
• W3092362987 citedByCount "11" @default.
• W3092362987 countsByYear W30923629872021 @default.
• W3092362987 countsByYear W30923629872022 @default.
• W3092362987 countsByYear W30923629872023 @default.
• W3092362987 crossrefType "journal-article" @default.
• W3092362987 hasAuthorship W3092362987A5012260179 @default.
• W3092362987 hasAuthorship W3092362987A5029554897 @default.
• W3092362987 hasAuthorship W3092362987A5032275750 @default.
• W3092362987 hasAuthorship W3092362987A5040815433 @default.
• W3092362987 hasAuthorship W3092362987A5044112673 @default.
• W3092362987 hasAuthorship W3092362987A5050357488 @default.
• W3092362987 hasAuthorship W3092362987A5059283543 @default.
• W3092362987 hasAuthorship W3092362987A5061152501 @default.
• W3092362987 hasAuthorship W3092362987A5075422062 @default.
• W3092362987 hasAuthorship W3092362987A5090770279 @default.
• W3092362987 hasBestOaLocation W30923629872 @default.
• W3092362987 hasConcept C111113717 @default.
• W3092362987 hasConcept C112705442 @default.
• W3092362987 hasConcept C126322002 @default.
• W3092362987 hasConcept C159641895 @default.
• W3092362987 hasConcept C177713679 @default.
• W3092362987 hasConcept C2776703206 @default.
• W3092362987 hasConcept C2777288759 @default.
• W3092362987 hasConcept C2778980435 @default.
• W3092362987 hasConcept C2779489039 @default.
• W3092362987 hasConcept C2780272996 @default.
• W3092362987 hasConcept C2908647359 @default.
• W3092362987 hasConcept C523546767 @default.
• W3092362987 hasConcept C54355233 @default.
• W3092362987 hasConcept C71924100 @default.
• W3092362987 hasConcept C86803240 @default.
• W3092362987 hasConcept C98274493 @default.
• W3092362987 hasConcept C99454951 @default.
• W3092362987 hasConceptScore W3092362987C111113717 @default.
• W3092362987 hasConceptScore W3092362987C112705442 @default.
• W3092362987 hasConceptScore W3092362987C126322002 @default.
• W3092362987 hasConceptScore W3092362987C159641895 @default.
• W3092362987 hasConceptScore W3092362987C177713679 @default.
• W3092362987 hasConceptScore W3092362987C2776703206 @default.
• W3092362987 hasConceptScore W3092362987C2777288759 @default.

• next